Neurotherapeutics

, Volume 6, Issue 2, pp 319–322 | Cite as

Commentary: A skeptical view of experimental gene therapy to block epileptogenesis

Theme 3: Gene Therapy

Summary

Gene therapy offers exciting new options for treating epileptic seizures, and even for blocking the development of epilepsy (i.e., epileptogenesis) after a brain insult. Although the available studies provide interesting new data, the experiments discussed in this issue also have limitations and raise concerns. The criticisms offered in this commentary center around the nature of the experimental testing (e.g., changes in seizure threshold), the animal models (e.g., kindling), and the measures of epileptogenesis in those animal models with spontaneous seizures (e.g., the latent period after pilocarpine-induced status epilepticus). Another set of criticisms relate to the relative lack of positive controls showing that the actual mechanism purported to be activated via the gene-therapeutic approach has in fact been upregulated in the specific animals that show the hypothetical antiepileptic result. This commentary takes the con side in the debate, to generate constructive criticism to help direct future studies to provide increasingly stronger data to support the view that gene therapy approaches may be useful in the treatment of epilepsy.

Key Words

Epilepsy seizures status epilepticus kindling seizure threshold 

References

  1. 1.
    Lin EJD, Richichi C, Young D, Baer K, Vezzani A, During MJ. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 2003; 18: 2087–2092.CrossRefPubMedGoogle Scholar
  2. 2.
    Foti S, Haberman RP, Samulski RJ, McCown TJ. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Ther 2007; 14: 1534–1536.CrossRefPubMedGoogle Scholar
  3. 3.
    Richichi C, Lin EJD, Stefanin D, et al. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 2004;24: 3051–3059.CrossRefPubMedGoogle Scholar
  4. 4.
    Walker MC, White HS, Sander JWAS. Disease modification in partial epilepsy. Brain 2002;125: 1937–1950.CrossRefPubMedGoogle Scholar
  5. 5.
    Raol YH, Lund IV, Bandyopadhyay S, et al. Enhancing GABAA receptor α1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 2006;26: 11342–11346.CrossRefPubMedGoogle Scholar
  6. 6.
    Lehmkuhle MJ, Thomson KE, Scheerlinck P, Pouliot W, Greger B, Dudek FE. A simple quantitative method for analyzing electrographic status epilepticus in rats. J Neurophysiol 2009 Jan. 7 (Epub ahead of print).Google Scholar
  7. 7.
    Bertram EH, Cornett J. The ontogeny of seizures in a rat model of limbic epilepsy: evidence for a kindling process in the development of chronic spontaneous seizures. Brain Res 1993;625: 295–300.CrossRefPubMedGoogle Scholar
  8. 8.
    Bertram EH, Cornett JF. The evolution of a rat model of chronic spontaneous limbic seizures. Brain Res 1994;661: 157–162.CrossRefPubMedGoogle Scholar
  9. 9.
    Williams PA, White AM, Clark S, Ferraro DJ, Swiercz W, Staley KJ, Dudek FE. Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J Neurosci 2009;29: 2103–2122.CrossRefPubMedGoogle Scholar
  10. 10.
    Noè F, Pool AH, Nissinen J, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 2008;131: 1506–1515.CrossRefPubMedGoogle Scholar
  11. 11.
    Thompson K. Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy. Neurotherapeutics 2009;6: 284–294.CrossRefPubMedGoogle Scholar
  12. 12.
    Riban V, Fitzsimons HL, During MJ. Gene therapy in epilepsy. Epilepsia 2009;50: 24–32.CrossRefPubMedGoogle Scholar

Copyright information

© The American Society for Experimental NeuroTherapeutics, Inc. 2009

Authors and Affiliations

  1. 1.Department of PhysiologyUniversity of Utah School of MedicineSalt Lake City

Personalised recommendations